Metabolic Dysfunction-associated Steatotic Liver Disease
📧 Sign up to get email alerts when something new happens for Metabolic Dysfunction-associated Steatotic Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: Aspirin for Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease [Phase 2]
A Phase 2 clinical trial is evaluating aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: Digital Diet and Exercise Intervention to Reduce Liver Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) [Phase 4]
Phase 4 clinical trial evaluating a digital diet and exercise program to reduce liver fibrosis in Metabolic Dysfunction-Associated Steatotic…
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: Long-term Follow-up to Determine Outcome in Liver Disease (LOVE Study)
This clinical trial update describes the LOVE study's long-term follow-up to determine outcomes in MASLD/MASH and related steatotic liver di…
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Single-Cell Profiling of Liver-infiltrating Immune Cells of Patients with NASH- and Virus-related HCC: Implications for Immunotherapy
A completed single-cell profiling study of liver-infiltrating immune cells in hepatocellular carcinoma associated with MASLD or hepatitis C …
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Clinical Correlation Evaluation of the LIVERFASt Test for Diagnosing Important Liver Lesions of Fibrosis and Steatosis Against Magnetic Resonance Elastography (MRE) for Liver Fibrosis and MR-based Assessment of Steatosis, in Adult US Population.
Clinical trial evaluating the LIVERFASt diagnostic test for diagnosing liver fibrosis and steatosis, using MR elastography as a reference st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Risk of MASLD in Adults in Romania
A completed clinical trial conducted in Romania evaluated risk factors for Metabolic dysfunction-associated steatotic liver disease (MASLD) …
-
CLINICAL_TRIALS research · 2025-03-10Clinical Trial Update: Metabolic Features Effects on FAST Score in MASLD Patients
Clinical trial update indicates a study examining the effects of metabolic features on the FAST score in MASLD patients and is currently rec…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease [NA]
A clinical trial assessing the impact of a healthy Nordic diet on atherosclerosis in patients with coronary heart disease; the study is curr…
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Antidiabetic Drugs for Steatotic Liver Disease [Phase 4]
Phase 4 clinical trial update evaluating antidiabetic drugs for steatotic liver disease (MASLD) and type 2 diabetes; the study has completed…
-
CLINICAL_TRIALS research · 2025-02-27Clinical Trial Update: Korean Health Screening-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Registry
A clinical trial registry entry from Korea University describes a health screening-based registry for Metabolic Dysfunction-Associated Steat…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients with Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) Placement [NA]
A clinical trial update describing a study that assesses cardiac function using MRI and echocardiography in patients with alcohol-related li…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH
A clinical trial evaluating prognostic factors for hepatocellular carcinoma and liver transplantation in patients with MASLD/MASH; recruitme…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Cardiac Dysfunction in Patients with Fatty Liver Disease
A recruiting clinical trial sponsored by the Post Graduate Institute of Medical Education and Research in Chandigarh evaluating cardiac dysf…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: COmmencing Menopausal HOrmone Replacement Therapy and the Effect on Metabolic-dysfunction Associated Steatotic Liver Disease: a Pilot Mechanistic Study [Phase 1]
Phase 1 pilot mechanistic study evaluating the effects of menopausal hormone replacement therapy on Metabolic Dysfunction Associated Steatot…
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM [Phase 4]
Phase 4 clinical trial update evaluating henagliflozin for liver fibrosis in patients with MASLD and type 2 diabetes; the study is currently…
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: MASLD Butyrate Supplementation Treatment Efficacy Review [Phase 3]
Phase 3 trial evaluating butyrate supplementation for MASLD is under efficacy review; no results or status details are provided in the updat…
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 study of TVB-2640 in MASLD/MASH/NASH has completed with results posted.
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Assessment of FibbroScan in Diagnosing MASLD Among the Chinese Population With Obesity
An ongoing clinical study assessing the use of FibroScan to diagnose metabolic dysfunction-associated steatotic liver disease (MASLD) in obe…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic Fibrosis in MASlD With type2 Diabetes Mellitus
This clinical trial update describes a study evaluating whether serum adiponectin and resistin levels correlate with the degree of hepatic f…
-
CLINICAL_TRIALS research · 2024-11-26Clinical Trial Update: Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLD [NA]
Ongoing clinical trial evaluating TOTUM-448 for reducing liver fat and improving metabolic risk factors in MASLD, with current recruitment s…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Impact of Live Streaming Exercise on Liver Health in MASLD Pregnant Women [NA]
The document outlines a clinical trial evaluating whether live-streamed exercise improves liver health in pregnant women with MASLD, current…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
This document provides an update on the development of new non-invasive biomarkers for metabolic dysfunction-associated steatotic liver dise…
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: Usefulness of Ultrasound-derived Fat Fraction for Quantification of Hepatic Steatosis in Patients Suspected of MASLD
This study evaluates ultrasound-derived fat fraction as a noninvasive method to quantify hepatic steatosis in patients suspected of Metaboli…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver Diseases [NA]
A clinical study funded by Jinling Hospital in China is evaluating hyperbaric oxygen therapy for metabolic dysfunction-associated steatotic …
-
CLINICAL_TRIALS research · 2024-09-24Clinical Trial Update: Endoscopic Ultrasound Shear Wave for Liver Fibrosis in MASLD Patients: The RUMIPAMBA Trial [NA]
A clinical trial evaluating endoscopic ultrasound shear wave elastography for assessing liver fibrosis in patients with MASLD is currently r…